Inhibition of neurofibrosarcoma growth and angiogenesis

Details Inhibition of neurofibrosarcoma growth and angiogenesis Inhibition of neurofibrosarcoma growth and angiogenesis

1992-08-05

2000-07-18

Fonda, Kathleen K.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514 26, 514 54, 514 58, 514169, A61K 31725

Patent

active

060907940

ABSTRACT:
A method for treating a neurofibrosarcoma tumor comprising administration of heparin and an angiostatic steroid is disclosed. Animal models for the growth of neurally-derived tumors and for testing therapeutic agents are also provided.

REFERENCES:
patent: 4596795 (1986-06-01), Pitha
patent: 4710493 (1987-12-01), Landsberger
patent: 4757056 (1988-07-01), Vangorp et al.
patent: 4788307 (1988-11-01), Lormeau et al.
patent: 4877774 (1989-10-01), Pitha et al.
patent: 4994443 (1991-02-01), Folkman et al.
patent: 5001116 (1991-03-01), Folkman et al.
patent: 5019562 (1991-05-01), Folkman et al.
patent: 5021404 (1991-06-01), Folkman et al.
Storm et al; Cancer 45:126-129 (1980).
Sieb et al; Dtsch. Med. Wschr. 114(11):417-419 Mar. 1989.
Dillman et al; Mol. Biother. 4:117-121 (1992).
Johnson and Goldin, Cancer Treatment Reviews 1975, (2), 1-31.
Dorland's Pocket Medical Dictionary, 24.sup.th Edition, W.B. Sanders Company, 1989, pp. 529 and 532.
Folkman et al; Science 221:719-725 (1983).
Crum et al; Science 230:1375-1378 (1985).
Ziche, et al., Int. J. Cancer:35, 549-552 (1985).
Sakamoto, et al., JNCI, vol. 78, No. 3, pp. 581-585, (Mar. 1987).
Rong, et al., Cancer, 57:586-590, (1986).
Penhaligon, et al., JNCI, vol. 74, No. 4, pp. 869-873, (Apr. 1985).
Lee, et al., Cancer Research, 47:5021-5024, Oct. 1, 1987.
Choay, Seminars in Thrombosis and Hemostatis, vol. 11, No. 2, pp. 81-85 (1985).
Barzu, et al., Biochimica et Biophysica Acta, 845:196-203 (1985).
Folkman, New Eng. J. of Med., vol. 285, No. 21, pp. 1182-1186, Nov. 18, 1971.
Wadzinski, et al., Clin. Physiol. Biochem., 5:200-209 (1987).
Thompson, et al., Science, vol. 241, 1349-1352 (1988).
Folkman, J., Ann. Surg., "Anti-Angiogenesis: New Concept for Therapy of Solid Tumors," vol. 175, No. 3, pp. 409-416, Mar. 1972.
Folkman, J., Biochemical Pharmacology, vol. 34, No. 7, pp. 905-909 (1985).
Folkman, et al., Science, vol. 235, 442-447 (1987).
Folkman, et al., Science, vol. 243, 1490-1493 (1989).
Medhkour, et al., J. Neurosurg., vol. 71, pp. 545-550 (1989).
Folkman, Advances in Cancer Research, vol. 43, pp. 175-203 (1985).
Lee, J.K., et al., J. Neurosurg., vol. 73, 429-435 (1990).
Lee, J.K., et al., Neurosurgery, vol. 26, No. 4, pp. 598-605 (1990).
Lee, J.K. et al., "Inhibition of Growth and Angiogenesis of Human Neurofibrosarcoma by Heparin and Hydrocortisone", J. Neurosurg. 73:429-435 (Sep. 1990).
Lee, J.K. et al., "Growth of Human Schwannomas in the Subrenal Capsule of the Nude Mouse", Neurosurgery 26(4):598-605 (Apr. 1990).
Medhkour et al., "Implantation of Human Meningiomas into the Subrenal Capsule of the Nude Mouse", J. Neurosurg. 71:545-550 (Oct. 1989).
Armstrong et al., "Liquid Chromatographic Separtion of Diastereomers and Structural Isomers on Cyclodextrin-Bonded Phases", Anal. Chem. 57(1):234-237 (Jan. 1985).
Bergeron, R.J., "Cycloamylose-Substrate Binding",Inclusion Compounds III, pp. 391-443, Academic Press, London (1984).
Choay et al., "Structure-Activity Relationship in Heparin: A Synthetic Pentasaccharide with High Affinity for Antithrombin III and Eliciting High Anti-factor Xa Activity", Biochem. Biophys. Res. Comm. 116(2):492-499 (Oct. 31, 1983).
Frank, S.G. and Kavaliunas,, D.R., "Investigation of the .beta.-Cyclodextrin-Hydrocortisone Inclusion Compound", J. of Pharm. Sciences 72(10):1215-1217 (Oct. 1983).
Saenger, W., Inclusion Compounds, vol. 2, pp. 235-259, Atwood et al. (Eds.), Academic Press, New York (1984).
Szejtli, J., "Industrial Applications of Cyclodextrins", Inclusion Compounds III, pp. 331-381, Academic Press, London (1984).
Tabushi, I., "Reactions of Inclusion Complexes Formed by Cyclodextrins and Their Derivatives", Inclusion Compounds III, pp. 445-471, Academic Press, London (1984).
van Boeckel et al., "Synthesis of a Potent Antithrombin Activating Pentasaccharide: A New Heparin-Like Fragment Containing Two 3-0-Sulphated Glucosamines", Tetrahedron Letters 29(7):803-806 (1988).

Affiliated with

Also associated with

Rating

Inhibition of neurofibrosarcoma growth and angiogenesis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibition of neurofibrosarcoma growth and angiogenesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of neurofibrosarcoma growth and angiogenesis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2037260